N
LJPC

Nuveen’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Nuveen’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-146,256
Closed -$620K – 3670
2021
Q1 		$620K Sell
146,256
-12,851
-8% -$70.8K ﹤0.01% 3048
2020
Q4 		$617K Buy
159,107
+22,591
+17% +$96.5K ﹤0.01% 2982
2020
Q3 		$551K Buy
136,516
+7,169
+6% +$29.7K ﹤0.01% 2923
2020
Q2 		$551K Buy
129,347
+44,550
+53% +$271K ﹤0.01% 2862
2020
Q1 		$356K Buy
84,797
+7,619
+10% +$48.1K ﹤0.01% 2890
2019
Q4 		$303K Sell
77,178
-6,575
-8% -$38.8K ﹤0.01% 3008
2019
Q3 		$737K Sell
83,753
-4,833
-5% -$45.7K ﹤0.01% 2819
2019
Q2 		$820K Buy
+88,586
New +$668K ﹤0.01% 2816

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen's LJPC Position: Q2 2021 in Review

Nuveen sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2021, closing a stake of 146,256 shares — an estimated $620K sold.

Nuveen first reported a position in LJPC in Q2 2019 and held it in 8 quarters. The position peaked at $820K in Q2 2019. 62 funds tracked by Wall St. Rank hold LJPC as of Q2 2021.

  • Nuveen reported no remaining La Jolla Pharmaceutical Company position as of Q2 2021 after selling out during the quarter.
  • Nuveen sold 146,256 La Jolla Pharmaceutical Company shares in Q2 2021, an estimated $620K.
  • Nuveen first reported a position in La Jolla Pharmaceutical Company in Q2 2019 and held it in 8 quarters.
  • Nuveen's La Jolla Pharmaceutical Company position peaked at $820K in Q2 2019.
  • 62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.